期刊文献+

桃红四物汤合蝮蛇抗栓酶治疗不稳定型心绞痛 被引量:3

Taohong Siwu Decoction combined with Venomin Antiembolic Enzyme in the Treatment of Non-stable Heart Pain
下载PDF
导出
摘要 目的 :观察中药桃红四物汤加味结合蝮蛇抗栓酶治疗不稳定型心痛疗效。方法 :所选 70例随机分为治疗组、对照组。两组均予常规抗心绞痛及蝮蛇抗栓酶治疗 ,治疗组加服桃红四物汤加味 ,每日 1剂 ,水煎早晚分服 ,根据辨证 ,随证加减。结果 :治疗组与对照组总有效率分别为 87 5 %和 70 2 %。两组比较有显著差异 (P <0 0 5 )。结论 :桃红四物汤加味结合蝮蛇抗栓酶对不稳定型心绞痛治疗有显著效果 ,二者起相辅相成的作用 ,且无明显毒副反应。 Purpose :To observe the efficacy of peach core and red flower added to other kinds of herbs(Taohong Siwu decoction)combined with venomin antiembolic enzyme in the treatment of non stable heart pain. Methods :70 cases of patients were randomly separated into 2 groups.All patients were treated with usual anti heart pain medication and venomin antiembolic enzyme.The treated group was also medicated to take Taohong Siwu decoction.The decoction was taken in the morning and evening separately once per day,which was water cooked,and the content of other kinds of herbs,dialectically,was add or reduced according to signs. Results :the efficacies of the treated group and the compared group were 87 5% and 70 2% separately.There exists great difference( P <0 05). Conclusions :There is distinguished efficacy in the treatment of non stable heart pain with Taohong Siwu decoction combined with venomin antiembolic enzyme.The two kinds of medicine could help each other and there are no obvious poisonous and side effects.
作者 芮以融
出处 《辽宁中医杂志》 CAS 2002年第11期674-675,共2页 Liaoning Journal of Traditional Chinese Medicine
关键词 桃红四物汤 蝮蛇抗栓酶 治疗 不稳定型心绞痛 non stable heart pain Taohong Siwu decoction venomin antiembolic enzyme
  • 相关文献

参考文献4

二级参考文献7

  • 1Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
  • 2Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
  • 3Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
  • 4Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.
  • 5Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280.
  • 6Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150.
  • 7Greory Y H, Gordon D L. Fibrin D-dimer: A useful marker of thrombogenesis? Clini Sci,1995(89):205-214.

共引文献467

同被引文献25

  • 1舒可成.红花注射液的临床应用进展[J].中国实用医药,2006,1(9):71-73. 被引量:13
  • 2陈可冀,李连达,翁维良.血瘀证与活血化瘀研究[J].中西医结合心脑血管病杂志,2005,3(1):1-2. 被引量:243
  • 3吴以岭.络病病机探析[J].中医杂志,2005,46(4):243-245. 被引量:133
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33037
  • 5脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15755
  • 6贾建平.神经病学[M]6版北京:人民卫生出版社,2008:176.
  • 7Tarling E J.Impaired development of atherosclerosis in Abcgl-/- Apoe-/- mice: identification of specific oxysterols that both accumulate in Abcgl-/- Apoe-/- tissues and induce apoptosis[ J ]. Arterioscler Thromb Vasc Biol, 2010,30 ( 6 ) : 1174-1180.
  • 8Ebert T, M Fasshauer.Tumor necrosis factor-related apoptosis- inducing ligand and cardiovascular disease[ J ] .Atherosclerosis, 2011,215 ( 2): 279-280.
  • 9Yonehara S, A Ishii, M Yonehara.A cell-killing monoclonal antibody ( anti-Fas )to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor[ J ] . J Exp Med, 1989, 169 ( 5 ): 1747-1756.
  • 10Thornben'y NA, Rano TA, Peterson EP, et al.A combinatorial approach defines specificities of members of the Caspase family and granzyme B [ J ] .J Biol C hem, 1997,272:17907-17911.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部